Clinical Trial Update: Assessment of Tear Film Thickness by Optical Coherence Tomography in Healthy Subjects and Subjects With Dry Eye Disease [Phase 3]

View source ↗

Summary

The Phase 3 trial assessing tear film thickness by optical coherence tomography in healthy subjects and in patients with dry eye disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Snippet

Sponsor: Medical University of Vienna | Conditions: Dry Eye Syndrome | Phase 3 | Status: WITHDRAWN